Analysis of Length of Stay (LOS) of Diabetes Mellitus Patients with COVID-19 Confirmed at One of Bantul Private Hospitals
Downloads
Diabetes mellitus (DM) is one of the most common health problems affecting millions of people in the world. Based on data from the Indonesian COVID-19 Handling Task Force, as of May 2021, it is known that the prevalence of DM as a comorbid COVID-19 is 33.6%. The variety of clinical conditions that accompany DM cases makes the complexity of patient care increase, which results in variations in patient LOS as one of the quality indicators to support better management and to improve the quality of service for DM patients confirmed with COVID-19 and not confirmed COVID-19. The purpose of this study was to determine whether or not there is a difference in the Length of Stay (LOS) of DM patients confirmed with COVID-19 and not confirmed with COVID-19 with the type of observational analytic cross-sectional design. Result Research shows that based on the Mann-Whitney test used to determine the difference in length of stay between DM patients confirmed with COVID-19 and not confirmed COVID-19, they get significant results, namely p-value = 0.000 (p<0.050). It can be concluded that there is a difference between the Length Of Stay (LOS) of Diabetes Miletus patients confirmed with COVID-19 and diabetes mellitus patients who are not confirmed with COVID-19.
Downloads
Indonesia. Hari Diabetes Sedunia Tahun 2018. Jakarta: Kementerian Kesehatan RI Pusat Data dan Informasi; 2019.
Manaithiya A, Alam O, Sharma V, Javed Naim M, Mittal S, Khan IA. GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus. Bioorganic Chemistry. 2021;113(1):104998. doi: 10.1016/j.bioorg.2021.104998
World Health Organization. Executive Summary Global Report On Diabetes. France: World Health Organization; Geneva, 2016.
International Diabetes Federation. Worldwide toll of diabetes. Jakarta: Kementerian Kesehatan RI Pusat Data dan Informasi; 2019.
Setiyani Y, Fatimah FS, Sumarsi S. Hubungan Pemberian Discharge Planning dengan Kecemasan pada Pasien Diabetes Melitus. Indonesian Journal of Hospital Administration. 2018;1(2):89–96. doi: http://dx.doi.org/10.21927/ijhaa.2018.1(2).89-96.
Koliaki C, Tentolouris A, Eleftheriadou I, Melidonis A, Dimitriadis G, Tentolouris N. Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns. Journal of Clinical Medicine. 2020 Jul 18;9(7):2288. doi: 10.3390/jcm9072288.
Karyono DR, Wicaksana AL. Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. Journal of community empowerment for health. 2020;3(2):77-84. doi: https://doi.org/ 10.22146/jcoemph.57325
Rajpal A, Rahimi L, Ismail-Beigi F. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. Journal of Diabetes. 2020;12(12):895-908. doi: 10.1111/1753-0407.13085
Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes and Metabolic Syndrome. 2020;14(3):211-212. doi: 10.1016/j.dsx.2020.03.002
Lubis IK, Susilawati S. Analisis Length Of Stay (Los) Berdasarkan Faktor Prediktor Pada Pasien DM Tipe II di RS PKU Muhammadiyah Yogyakarta. Jurnal Kesehatan Vokasional. 2018;2(2):161. doi: https://doi.org/10.22146/jkesvo.30330
Salim MF, Lubis IK, Sugeng S. Perbedaan Length of Stay (LOS) Pasien Diabetes Mellitus Berdasarkan Komplikasi Di RSUP Dr. Sardjito Yogyakarta. Jurnal Manajemen Informasi Kesehatan Indonesia 2019;7(1):17. doi: https://jmiki.aptirmik.or.id/jmiki/article/view/10
Kistianita AN, Yunus M, Gayatri RW. Analisis Faktor Risiko Diabetes Mellitus Tipe 2 Pada Usia Produktif Dengan Pendekatan Who Stepwise Step 1 (Core/Inti) Di Puskesmas Kendalkerep Kota Malang. Indonesia Journal of public health. 2018;3(1):85-108. doi: http://dx.doi.org/ 10.17977/um044v3i1p85-108
Nafiah, D. Health-Related Quality of Life Penderita Diabetes Mellitus di Masa Pandemi COVID-19. HIGEIA (Journal of Public Health Research and Development). 2021;5(4):556-68. doi: https://doi.org/10.15294/higeia.v5i4.49723
Smeltzer S, Brunner & Suddarth. Buku Keperawatan Medikal Bedah Edisi 12. Jakarta: EGC; 2014.
Sticchi A, Cereda A, Toselli M, Esposito A, Palmisano A, Vignale D, et al. Diabetes and mortality in patients with COVID-19 : Are we missing the link? Anatolian Journal of Cardiology. 2021;25(6):376-79. doi: 10.5152/AnatolJCardiol.2021.29132.
Rashedi J, Mahdavi Poor B, Asgharzadeh V, Pourostadi M. Risk Factors for COVID-19. Infezioni in Medicina. 2020;28(4):469-74.
Belice T, Demir I. The gender differences as a risk factor in diabetic patients with COVID-19. Iranian Journal of Microbiology. 2020;12(6):625-28. doi: 10.18502/ijm.v12i6.5038
Nurida Alfi Mustafida, Diyantoro, Aliyah Siti Sundari, Dwi Wahyu Indriati Prevalence of Diabetes Mellitus Comorbidity in COVID-19 Patients Treated at Selected Hospital in Surabaya. International Journal of Scientific Research in Biological Sciences. 2022;9(1):32-4.
Sheshah E, Sabico S, Albakr RM, Sultan AA, Alghamdi KS, Al K, et al. Prevalence of diabetes, management and outcomes among Covid-19 adult patients admitted in a specialized tertiary hospital in Riyadh , Saudi Arabia. Diabetes Research and Clinical Practice. 2021;173(1):108538. doi: https://doi.org/10.1016/j.diabres.2020.108538
Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N New England Journal of Medicine. 2020;382(21):2012-22. doi: 10.1056/ NEJMoa2004500
Wang L, Gao YH, Lou LL, Zhang GJ. The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China. European Respiratory Journal. 2020;55(4):2000398. doi: 10.1183/13993003.00398-2020
Trusda SAD, Purbaningsih W, Budiman B, Fitriadi SSN. Characteristics of patients with type 2 diabetes mellitus in Al-Ihsan regional general hospital. Global Medical and Health Communication. 2021;9(2):150-7. doi: https://doi.org/10.29313/ gmhc.v9i2.8123
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice. 2022;183:109119. doi: 10.1016/j.diabres.2021.109119
Hidayat B, Ramadani RV, Rudijanto A, Soewondo P, Suastika K, Siu Ng JY. Direct Medical Cost of Type 2 Diabetes Mellitus and Its Associated Complications in Indonesia. Value in Health Regional Issues. 2022;28:82-9. doi: 10.1016/j.vhri.2021.04.006
Lestari N, Ichsan B. Diabetes Melitus Sebagai Faktor Risiko Keparahan dan Kematian Pasien COVID-19 : Meta-Analisis. Biomedika. 2021;13(1):83–94. doi: 10.23917/biomedika.v13i1.13544
Bode B, Garrett V, Messler J, McFarland R, Crowe J, Booth R, et al. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. Journal of Diabetes Science and Technology. 2020;14(4):813-21. doi: 10.1177/1932296820924469
Raran KNW, Annisa A. Pengaruh Penyakit Komorbid Diabetes Melitus terhadap Recovery Time pada Pasien COVID-19 di RSUP Dr. M Djamil Padang. Jurnal Implementa Husada. 2022;14(4):201-9. doi: https:// jurnal.umsu.ac.id/index.php/JIH/article/view/12234/0
Alkundi A, Mahmoud I, Musa A, Naveed S, Alshawwaf M. Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre study. Diabetes Research and Clinical Practice. 2020;165:108263. doi: 10.1016/j.diabres.2020.108263
Wu J, Zhang J, Sun X, et al. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection. Diabetes, Obesity and Metabolism. 2020;22(10):1907-14. doi: 10.1111/dom.14105
Landstra CP, de Koning EJP. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course. Frontiers of Endocrinology (Lausanne). 2021;12:649525. Doi: 10.3389/fendo.2021.649525
Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. American Journal of Physiology-Endocrinology and Metabolism. 2020;318(5):736-41. doi: 10.1152/ajpendo.00124.2020
Copyright (c) 2023 Jurnal Kefarmasian Indonesia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
